Commission on Cancer Quality Measure for Omission of Sentinel Lymph Node Biopsy (SNB) in Women Age 70 or Older with Hormone Receptor-Positive (HR+) Invasive Breast Cancer (IBC) Undergoing Breast-Conserving Surgery (BCS): Review of Historical Performance.
Yee GN, Hwang S, Wilke LG, Freedman LM, Froix AJ, Ray E, Kuchta K, Eldridge L, Yao KA
Ann Surg Oncol 2026 Feb 21;
[PubMed ID: 41723318]Risk Counseling Tools for Contralateral Breast Cancer Risk After Genetic Testing.
Beck AC, Wilke LG, Lizarraga IM
JAMA Netw Open 2026 Jan 02; 9(1): e2551543
[PubMed ID: 41525079]Commission on Cancer Quality Measures: Time to Breast Operation Quality Measure.
Bleicher RJ, Hwang ES, Wilke LG, Freedman LM, Froix AJ, Ray EM, Sala CM, Park KU, Yao KA
J Am Coll Surg 2025 Dec 12;
[PubMed ID: 41384625]Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines.
Fracasso PM, Simone NL, Si Lim SJ, Reckamp KL, Sosa JA, Lieu C, Lee C, Werner TL, Ly QP, Vose JM, White J, Honeycutt H, Shaw K, Cameron K, O'Brien DM, Wilke LG
JCO Oncol Pract 2025 Sep 24; OP2500073
[PubMed ID: 40991878]Evolution in the Management of Axillary Lymph Nodes in Breast Cancer.
Wilke LG, Woodfin AA, Owusu-Brackett N, Beck AC
Adv Surg 2025 Sep; 59(1): 1-14
[PubMed ID: 40769688]
